Danske Bank’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6K Hold
100
– – ﹤0.01% 782
2026
Q1
$11.8K Sell
100
-700
-88% -$97.8K ﹤0.01% 788
2025
Q4
$131K Hold
800
– – ﹤0.01% 725
2025
Q3
$107K Hold
800
– – ﹤0.01% 850
2025
Q2
$99.5K Buy
+800
New +$102K ﹤0.01% 852
2024
Q4
– Sell
-200
Closed -$29.8K – 1603
2024
Q3
$29.8K Sell
200
-16,788
-99% -$2.41M ﹤0.01% 1280
2024
Q2
$2.14M Sell
16,988
-16,300
-49% -$2.55M 0.01% 619
2024
Q1
$6.12M Buy
+33,288
New +$6.34M 0.02% 533

Other funds holding RGEN

Danske Bank's RGEN Position: Q2 2026 in Review

Danske Bank held its Repligen (RGEN) position steady in Q2 2026 at 100 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Danske Bank first reported a position in RGEN in Q1 2024 and has held it in 8 quarters since. The position peaked at $6.12M in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Danske Bank held 100 shares of Repligen worth $13.6K as of Q2 2026.
  • Danske Bank left its Repligen share count unchanged in Q2 2026.
  • Repligen made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #782 holding.
  • Danske Bank first reported a position in Repligen in Q1 2024 and has held it in 8 quarters since.
  • Danske Bank's Repligen position peaked at $6.12M in Q1 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.